Can the Origin of Sperm Affect Embryo Ploidy in Patients With Severe Male Factor Infertility?
Can the Origin of Sperm - Ejaculated or Testicular- Affect Embryo Ploidy in Patients With Severe Male Factor Infertility?
1 other identifier
interventional
100
1 country
1
Brief Summary
There is evidence indicating that sperm plays a role in determining blastocyst ploidy status. In our study, we aim to compare the outcomes of preimplantation genetic testing for aneuploidy (PGT-A) and the subsequent clinical outcomes following transfers of euploid embryos. This comparison will be conducted between cases where ejaculated sperm and cases where testicular sperm were used for intracytoplasmic sperm injection (ICSI), specifically focusing on severe male factor infertility patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2024
CompletedStudy Start
First participant enrolled
June 25, 2024
CompletedFirst Posted
Study publicly available on registry
June 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedAugust 15, 2025
June 1, 2024
10 months
June 21, 2024
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Euploidy rate
Defined as the proportion of euploid blastocysts
15 days post ICSI
Aneuploidy rate
Defined as the proportion of aneuploid blastocysts
15 days post ICSI
Low mosaic rate
Defined as the proportion of low mosaic blastocysts
Time Frame: 15 days post ICSI
High mosaic rate
Defined as the proportion of high mosaic blastocysts
Time Frame: 15 days post ICSI
Implantation rate
defined as the percentage of successfully implanted embryos
6-9 weeks post-embryo transfer
Ongoing pregnancy rate
defined as a positive heartbeat on ultrasound beyond 12 weeks of gestation
12 weeks of gestation
Miscarriage rate
defined as pregnancy loss following confirmation of clinical pregnancy
after 6 weeks of gestation
Clinical pregnancy rate
defined as the presence of a fetal heartbeat or gestational sac 6-9 weeks post-embryo transfer
6-9 weeks post-embryo transfer
Secondary Outcomes (3)
Fertilization rate
1 day
Cleavage rate
3 days
Blastocyst development rate
5-6 days
Study Arms (2)
Ejaculate
ACTIVE COMPARATORPatients within this arm will undergo ICSI utilizing ejaculated sperm.
Testicular
ACTIVE COMPARATORPatients within this arm will undergo ICSI utilizing testicular sperm.
Interventions
Surgical procedure used to retrieve sperm directly from the testicles of men who have low sperm production or no sperm in their ejaculate
Eligibility Criteria
You may qualify if:
- Cases planned to have ICSI PGT-A cycles
- Males diagnosed as severe male factor infertility
- Normo responder female partners
You may not qualify if:
- Leukocytospermia
- Presence of varicocele.
- Known genetic abnormality
- Use of sperm or oocyte donors
- Use of gestational carrier
- Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection
- Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ganin Fertility Center
Cairo, Maadi, 11728, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eman Hasanen
Ganin Fertility Center
- STUDY CHAIR
Hosam Zaki, FRCOG
Ganin Fertility Center
- STUDY DIRECTOR
Refaat Gabre, PhD
Faculty of Science, Cairo University
- STUDY CHAIR
Mohamed Abbas
Cairo University
- STUDY CHAIR
Nahla Osama, Phd
Faculty of Science, Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2024
First Posted
June 26, 2024
Study Start
June 25, 2024
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
August 15, 2025
Record last verified: 2024-06